LIFECORE BIOMEDICAL, INC. Accounts Payable
LIFECORE BIOMEDICAL, INC. (LFCR) had Accounts Payable of $7.53 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-05
- 2026-06-30: Accounts Payable, Current $7.53M.
- 2026-03-31: Accounts Payable, Current $7.01M.
- 2025-12-31: Accounts Payable, Current $6.21M; Accounts Payable, Current as first filed $5.84M.
- 2025-09-30: Accounts Payable, Current $10.12M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $7.53M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $7.01M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $6.21M 10-Q · filed 2026-08-05 | $5.84M 10-KT · filed 2026-03-16 |
| 2025-09-30 | $10.12M 10-Q · filed 2025-11-06 | |
| 2025-05-25 | $8.22M 10-KT · filed 2026-03-16 | |
| 2025-02-23 | $7.41M 10-Q · filed 2025-04-03 | |
| 2024-11-24 | $14.97M 10-Q · filed 2025-01-02 | |
| 2024-08-25 | $18.01M 10-Q · filed 2024-10-04 | |
| 2024-05-26 | $16.33M 10-KT · filed 2026-03-16 | |
| 2024-02-25 | $15.69M 10-Q · filed 2024-08-09 | |
| 2023-11-26 | $19.02M 10-Q · filed 2024-08-09 | |
| 2023-08-27 | $15.69M 10-Q · filed 2024-08-09 | |
| 2023-05-28 | $22.10M 10-K · filed 2024-08-26 | |
| 2023-02-26 | $14.66M 10-K · filed 2024-03-20 | $14.76M 10-Q · filed 2023-06-02 |
| 2022-11-27 | $13.30M 10-K · filed 2024-03-20 | $27.97M 10-Q · filed 2023-03-16 |
| 2022-08-28 | $9.62M 10-K · filed 2024-03-20 | $16.37M 10-Q · filed 2022-10-07 |
| 2022-05-29 | $12.95M 10-K · filed 2024-03-20 | $15.80M 10-K · filed 2022-09-14 |
| 2022-02-27 | $13.29M 10-K · filed 2024-03-20 | $20.01M 10-Q · filed 2022-04-07 |
| 2021-11-28 | $8.65M 10-K · filed 2024-03-20 | $59.10M 10-Q · filed 2022-01-07 |
| 2021-08-29 | $8.61M 10-K · filed 2024-03-20 | $46.35M 10-Q · filed 2021-10-05 |
| 2021-05-30 | $11.62M 10-K · filed 2024-03-20 | $47.57M 10-K · filed 2021-07-29 |
| 2021-02-28 | $8.89M 10-K · filed 2024-03-20 | $56.32M 10-Q · filed 2021-04-08 |
| 2020-11-29 | $7.99M 10-K · filed 2024-03-20 | $60.89M 10-Q · filed 2021-01-07 |
| 2020-08-30 | $6.35M 10-K · filed 2024-03-20 | $50.72M 10-Q · filed 2020-10-07 |
| 2020-05-31 | $51.65M 10-K · filed 2021-07-29 | |
| 2020-02-23 | $63.66M 10-Q · filed 2020-04-03 | |
| 2019-11-24 | $47.15M 10-Q · filed 2020-01-02 | |
| 2019-08-25 | $46.16M 10-Q · filed 2019-10-03 | |
| 2019-05-26 | $53.97M 10-K · filed 2020-08-14 | |
| 2019-02-24 | $46.43M 10-Q · filed 2019-04-04 | |
| 2018-11-25 | $31.72M 10-Q · filed 2019-01-07 | |
| 2018-08-26 | $27.03M 10-Q · filed 2018-10-05 | |
| 2018-05-27 | $34.67M 10-K · filed 2019-08-01 | |
| 2018-02-25 | $35.24M 10-Q · filed 2018-04-05 | |
| 2017-11-26 | $37.48M 10-Q · filed 2018-01-05 | |
| 2017-08-27 | $26.95M 10-Q · filed 2017-09-28 | |
| 2017-05-28 | $24.53M 10-K · filed 2018-08-09 | $25.87M 10-K · filed 2017-08-11 |
| 2017-02-26 | $24.76M 10-Q · filed 2017-04-07 | |
| 2016-11-27 | $25.91M 10-Q · filed 2017-01-05 | |
| 2016-08-28 | $31.61M 10-Q · filed 2016-09-29 | |
| 2016-05-29 | $30.90M 10-K/A · filed 2018-03-15 | |
| 2016-02-28 | $25.09M 10-Q · filed 2016-03-30 | |
| 2015-11-29 | $36.92M 10-Q · filed 2016-01-07 | |
| 2015-08-30 | $31.95M 10-Q · filed 2015-10-01 | |
| 2015-05-31 | $35.01M 10-K · filed 2016-08-01 | $34.77M 10-K · filed 2015-07-31 |
| 2015-03-01 | $28.17M 10-Q · filed 2015-04-02 | |
| 2014-11-30 | $39.18M 10-Q · filed 2015-01-09 | |
| 2014-08-31 | $37.21M 10-Q · filed 2014-10-08 | |
| 2014-05-25 | $31.98M 10-K · filed 2015-07-31 | |
| 2014-02-23 | $29.63M 10-Q · filed 2014-03-28 | |
| 2013-11-24 | $34.52M 10-Q · filed 2014-01-03 | |
| 2013-08-25 | $29.08M 10-Q · filed 2013-09-26 | |
| 2013-05-26 | $32.03M 10-K · filed 2014-08-01 | $31.47M 10-K · filed 2013-08-07 |
| 2013-02-24 | $27.74M 10-Q · filed 2013-04-04 | |
| 2012-11-25 | $25.94M 10-Q · filed 2013-01-04 | |
| 2012-08-26 | $26.72M 10-Q/A · filed 2013-01-02 | |
| 2012-05-27 | $22.64M 10-K · filed 2013-08-07 | |
| 2012-02-26 | $14.45M 10-Q · filed 2012-03-28 | |
| 2011-11-27 | $18.89M 10-Q · filed 2012-01-05 | |
| 2011-08-28 | $18.16M 10-Q · filed 2011-10-05 | |
| 2011-05-29 | $16.75M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |